A detailed history of Humankind Investments LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Humankind Investments LLC holds 800 shares of REGN stock, worth $557,504. This represents 0.31% of its overall portfolio holdings.

Number of Shares
800
Previous 913 12.38%
Holding current value
$557,504
Previous $959,000 12.41%
% of portfolio
0.31%
Previous 0.26%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $115,722 - $135,798
-113 Reduced 12.38%
800 $840,000
Q2 2024

Aug 12, 2024

SELL
$883.2 - $1071.19 $53,875 - $65,342
-61 Reduced 6.26%
913 $959,000
Q1 2024

May 08, 2024

SELL
$902.69 - $993.35 $81,242 - $89,401
-90 Reduced 8.46%
974 $937,000
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $3,100 - $3,526
-4 Reduced 0.37%
1,064 $934,000
Q3 2023

Nov 13, 2023

SELL
$692.45 - $844.37 $49,856 - $60,794
-72 Reduced 6.32%
1,068 $878,000
Q2 2023

Aug 18, 2023

SELL
$700.03 - $830.35 $453,619 - $538,066
-648 Reduced 36.24%
1,140 $819,000
Q2 2023

Aug 09, 2023

BUY
$700.03 - $830.35 $628,626 - $745,654
898 Added 100.9%
1,788 $1.28 Million
Q1 2023

Apr 25, 2023

SELL
$680.49 - $826.97 $10,207 - $12,404
-15 Reduced 1.66%
890 $731,000
Q4 2022

Jan 26, 2023

SELL
$705.89 - $766.39 $115,765 - $125,687
-164 Reduced 15.34%
905 $0
Q3 2022

Nov 09, 2022

BUY
$573.97 - $724.32 $129,143 - $162,972
225 Added 26.66%
1,069 $736,000
Q2 2022

Aug 05, 2022

BUY
$548.35 - $738.84 $79,510 - $107,131
145 Added 20.74%
844 $499,000
Q1 2022

May 09, 2022

BUY
$595.12 - $698.43 $35,112 - $41,207
59 Added 9.22%
699 $488,000
Q4 2021

Mar 21, 2022

BUY
$543.48 - $670.97 $41,304 - $50,993
76 Added 13.48%
640 $404,000
Q3 2021

Mar 21, 2022

SELL
$574.03 - $680.96 $6,888 - $8,171
-12 Reduced 2.08%
564 $341,000
Q2 2021

Mar 21, 2022

BUY
$472.8 - $558.54 $272,332 - $321,719
576 New
576 $322,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.